How to set up a psychedelic study: Unique considerations for research involving human participants.

Saved in:
Bibliographic Details
Title: How to set up a psychedelic study: Unique considerations for research involving human participants.
Authors: Glennon MJ; Clinical Psychopharmacology Unit, Research Department of Clinical, Educational and Health Psychology, University College London, United Kingdom. Electronic address: m.glennon@ucl.ac.uk., Bird CIV; Psychoactive Trials Group, Institute of Psychiatry, Psychology and Neuroscience, King's College London, United Kingdom., Yadav P; Centre for Neuroimaging Sciences, King's College London, United Kingdom., Kleine P; Centre for Neuroimaging Sciences, King's College London, United Kingdom; Centre for Psychedelic Research, Department of Brain Sciences, Faculty of Medicine, Imperial College London, London, United Kingdom., Suseelan S; Centre for Neuroimaging Sciences, King's College London, United Kingdom., Boman-Markaki C; Centre for Neuroimaging Sciences, King's College London, United Kingdom., Kotoula V; Centre for Neuroimaging Sciences, King's College London, United Kingdom., Butler M; Centre for Neuroimaging Sciences, King's College London, United Kingdom., Leech R; Centre for Neuroimaging Sciences, King's College London, United Kingdom., Roseman L; Department of Psychology, University of Exeter, Exeter, United Kingdom; Centre for Psychedelic Research, Department of Brain Sciences, Faculty of Medicine, Imperial College London, London, United Kingdom., Erritzoe D; Centre for Psychedelic Research, Department of Brain Sciences, Faculty of Medicine, Imperial College London, London, United Kingdom., Srivastava DP; Department of Basic and Clinical Neuroscience, Institute of Psychiatry Psychology and Neuroscience, King's College London, United Kingdom; MRC Centre for Neurodevelopmental Disorders, King's College London, United Kingdom., Morgan C; Department of Psychology, University of Exeter, Exeter, United Kingdom., Timmermann C; Experimental Psychology, Psychology and Language Sciences, University College London, United Kingdom; Centre for Psychedelic Research, Department of Brain Sciences, Faculty of Medicine, Imperial College London, London, United Kingdom., Cooper G; Clinical Psychopharmacology Unit, Research Department of Clinical, Educational and Health Psychology, University College London, United Kingdom., Skipper JI; Experimental Psychology, Psychology and Language Sciences, University College London, United Kingdom., Rucker J; Psychoactive Trials Group, Institute of Psychiatry, Psychology and Neuroscience, King's College London, United Kingdom; The Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, United Kingdom; South London and Maudsley NHS Foundation Trust, London, United Kingdom., Kamboj SK; Clinical Psychopharmacology Unit, Research Department of Clinical, Educational and Health Psychology, University College London, United Kingdom., Mehta MA; Centre for Neuroimaging Sciences, King's College London, United Kingdom., Das RK; Clinical Psychopharmacology Unit, Research Department of Clinical, Educational and Health Psychology, University College London, United Kingdom., Bhat A; Centre for Neuroimaging Sciences, King's College London, United Kingdom; Department of Psychology, University of Exeter, Exeter, United Kingdom.
Source: Neuroscience and biobehavioral reviews [Neurosci Biobehav Rev] 2026 Jul; Vol. 186, pp. 106657. Date of Electronic Publication: 2026 Mar 23.
Publication Type: Journal Article; Review
Journal Info: Publisher: Pergamon Press Country of Publication: United States NLM ID: 7806090 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7528 (Electronic) Linking ISSN: 01497634 NLM ISO Abbreviation: Neurosci Biobehav Rev Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1873-7528
DOI:10.1016/j.neubiorev.2026.106657